Japan's attempts to import swine flu vaccine may be too late

Aug 23, 2009 The Yomiuri Shimbun

The Japanese government might not be able to import vaccine to combat the new type of influenza -- the H1N1 virus, or swine flu -- before autumn, when an epidemic of the disease is feared will intensify, as experts want pre-import confirmation that the vaccine is safe for Japanese patients, sources familiar with the matter said.

According to the sources, the three Western pharmaceutical companies that manufacture the vaccine have submitted terms of contract, among which the government is asked to exempt them from liability in case the vaccine causes side effects. Additionally, the firms indicated they would prioritize shipments to other countries unless the contract is signed by the end of this month.

The companies likely offered such tough terms because of expectations of a new-flu vaccine shortage around October or November, when the Northern Hemisphere enters its winter flu season.

Last month, Health, Labor and Welfare Minister Yoichi Masuzoe said the nation would need vaccine for 53 million people. The health ministry was negotiating with the foreign pharmaceutical firms to import 15 million to 20 million doses to cover an expected shortage that domestic makers cannot cover.

The ministry intends to accept the contract terms so it can import the vaccine as soon as possible, the sources said. Therefore, it asked a government advisory panel to examine the advisability of importing the vaccine, which has undergone only overseas safety verification procedures, by applying the Pharmaceutical Affairs Law's "special approval" provision to this case, according to the sources.

However, many experts on the advisory panel opposed such a move, with one reportedly saying such approval cannot guarantee the safety of the vaccine because overseas vaccine-injection methods might be different from those of domestically produced vaccine, and foreign-made might contain immunopotentiating agents (that upon injection enhance ).
___

(c) 2009, The Yomiuri Shimbun
Visit the Daily Yomiuri Online at www.yomiuri.co.jp/index-e.htm/
Distributed by McClatchy-Tribune Information Services.

Explore further: Flu vaccine may hold key to preventing heart disease

add to favorites email to friend print save as pdf

Related Stories

Japan to start developing swine flu vaccine

May 04, 2009

The Japanese Health, Labor and Welfare Ministry announced Saturday the start of vaccine development against swine flu, following the arrival of a sample of the new type of flu strain at the National Institute of Infectious ...

Bird flu vaccine declared safe by testers

Aug 28, 2006

Chinese researchers said Monday that the first round of clinical tests of a bird flu vaccine for humans have found the treatment to be safe and effective.

WHO: Swine flu vaccine on track

Aug 06, 2009

(AP) -- Swine flu vaccine manufacturers are on track to start delivering the first batches of it in September, the World Health Organization said Thursday.

Recommended for you

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0